Michelle Leblanc Murphy
Sr Director, Pharmacology Toxicology (Bms Kendall Sq - Orbital Therapeutics) @Bristol Myers Squibb
Signup · Get unlimited contacts
WORK HISTORY
Sr Director, Pharmacology Toxicology (Bms Kendall Sq - Orbital Therapeutics) @Bristol Myers Squibb
Orbital Therapeutics was acquired by BMS in Dec 2025
EDUCATION
Barry University
Master’s Degree, Biological and Biomedical Sciences
Syracuse University
Bachelor of Science (B.S.), Biology, General
University of Miami Miller School of Medicine
Doctor of Philosophy (Ph.D.), Molecular and Cellular Pharmacology
ABOUT MICHELLE LEBLANC MURPHY
Senior Director of Pharmacology and Toxicology with over 10 years of hands-on experience in early-stage drug discovery and translational research. Molecular and cellular biologist by training, with deep scientific expertise in autoimmune, ocular, and liver-directed cell therapy programs. Directly involved in the design, execution, and interpretation of in vitro and in vivo pharmacology and toxicology studies supporting IND-enabling packages for novel therapeutic modalities.Extensive experience selecting relevant disease models, defining dose, exposure, and biomarker strategies, and integrating pharmacology, safety, and mechanistic data to inform development decisions. Proven people leader who works side-by-side with multidisciplinary teams across discovery, CMC, regulatory, and clinical functions to advance high-quality science from concept to clinic.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.